EC
TPST icon

EcoR1 Capital’s Tempest Therapeutics TPST Stock Holding History

EcoR1 Capital’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-71,615
Closed -$284K – 60
2023
Q3 		$284K Sell
71,615
-14,803
-17% -$142K 0.01% 49
2023
Q2 		$1.43M Buy
86,418
+7,090
+9% +$178K 0.04% 47
2023
Q1 		$2.39M Hold
79,328
– – 0.08% 43
2022
Q4 		$1.19M Hold
79,328
– – 0.04% 59
2022
Q3 		$1.79M Hold
79,328
– – 0.05% 63
2022
Q2 		$2.22M Buy
+79,328
New +$3.08M 0.08% 57
2017
Q4 		– Sell
-1,201
Closed -$4.99M – 42
2017
Q3 		$4.99M Hold
1,201
– – 0.66% 25
2017
Q2 		$5.48M Hold
1,201
– – 0.97% 18
2017
Q1 		$6.57M Buy
+1,201
New +$5.59M 1.66% 14
2016
Q1 		– Sell
-145
Closed -$4.15M – 41
2015
Q4 		$4.15M Buy
+145
New +$4.78M 1.3% 21

Other funds holding TPST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

EcoR1 Capital's TPST Position: Q4 2023 in Review

EcoR1 Capital sold out of Tempest Therapeutics (TPST) in Q4 2023, closing a stake of 71,615 shares — an estimated $284K sold.

EcoR1 Capital first reported a position in TPST in Q4 2015 and held it in 10 quarters. The position peaked at $6.57M in Q1 2017. 31 funds tracked by Wall St. Rank hold TPST as of Q4 2023.

  • EcoR1 Capital reported no remaining Tempest Therapeutics position as of Q4 2023 after selling out during the quarter.
  • EcoR1 Capital sold 71,615 Tempest Therapeutics shares in Q4 2023, an estimated $284K.
  • EcoR1 Capital first reported a position in Tempest Therapeutics in Q4 2015 and held it in 10 quarters.
  • EcoR1 Capital's Tempest Therapeutics position peaked at $6.57M in Q1 2017.
  • 31 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2023.

Based on EcoR1 Capital's 13F filing for Q4 2023, filed 14 Feb 2024.